Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to cre... Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to create functional tissue. Its product candidate FX-322 is being developed for treating sensorineural hearing loss. Show more
CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA...
- Submitted regulatory filing for first-in-human clinical study of KRRO-110 in patients with alpha-1 antitrypsin deficiency (AATD) - Formed Clinical Advisory Board (CAB) of leading lung and liver...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -25.44 | -35.4268207771 | 71.81 | 72.51 | 46.1918 | 162787 | 54.25755869 | CS |
4 | -29.63 | -38.9868421053 | 76 | 77.13 | 46.1918 | 132734 | 62.51682761 | CS |
12 | -1.83 | -3.79668049793 | 48.2 | 98 | 30.74 | 120498 | 60.05335014 | CS |
26 | -9.62 | -17.1816395785 | 55.99 | 98 | 30.005 | 99309 | 51.37589779 | CS |
52 | 10.1 | 27.8467052661 | 36.27 | 98 | 30.005 | 67862 | 53.11841305 | CS |
156 | 33.37 | 256.692307692 | 13 | 98 | 13 | 70545 | 52.10510752 | CS |
260 | 33.37 | 256.692307692 | 13 | 98 | 13 | 70545 | 52.10510752 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales